BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 21986312)

  • 1. Interleukin-5 and IL-5 receptor in health and diseases.
    Takatsu K
    Proc Jpn Acad Ser B Phys Biol Sci; 2011; 87(8):463-85. PubMed ID: 21986312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allergic diseases: From bench to clinic - Contribution of the discovery of interleukin-5.
    Yanagibashi T; Satoh M; Nagai Y; Koike M; Takatsu K
    Cytokine; 2017 Oct; 98():59-70. PubMed ID: 28863833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin 5 in the link between the innate and acquired immune response.
    Takatsu K; Kouro T; Nagai Y
    Adv Immunol; 2009; 101():191-236. PubMed ID: 19231596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-5 and eosinophilia.
    Takatsu K; Nakajima H
    Curr Opin Immunol; 2008 Jun; 20(3):288-94. PubMed ID: 18511250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-5- and eosinophil-mediated inflammation: from discovery to therapy.
    Kouro T; Takatsu K
    Int Immunol; 2009 Dec; 21(12):1303-9. PubMed ID: 19819937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Role of interleukin-5 in immune regulation and inflammation].
    Takatsu K
    Nihon Rinsho; 2004 Oct; 62(10):1941-51. PubMed ID: 15500144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-5 and IL-5 receptor in asthma.
    Kotsimbos AT; Hamid Q
    Mem Inst Oswaldo Cruz; 1997; 92 Suppl 2():75-91. PubMed ID: 9698919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The mechanism of IL-5 signal transduction.
    Adachi T; Alam R
    Am J Physiol; 1998 Sep; 275(3):C623-33. PubMed ID: 9730944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular and clinical rationale for therapeutic targeting of interleukin-5 and its receptor.
    Molfino NA; Gossage D; Kolbeck R; Parker JM; Geba GP
    Clin Exp Allergy; 2012 May; 42(5):712-37. PubMed ID: 22092535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eosinophil apoptosis induced by fungal immunomodulatory peptide-fve via reducing IL-5alpha receptor.
    Hsieh CW; Lan JL; Meng Q; Cheng YW; Huang HM; Tsai JJ
    J Formos Med Assoc; 2007 Jan; 106(1):36-43. PubMed ID: 17282969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-33 Precedes IL-5 in Regulating Eosinophil Commitment and Is Required for Eosinophil Homeostasis.
    Johnston LK; Hsu CL; Krier-Burris RA; Chhiba KD; Chien KB; McKenzie A; Berdnikovs S; Bryce PJ
    J Immunol; 2016 Nov; 197(9):3445-3453. PubMed ID: 27683753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin 5 regulates the isoform expression of its own receptor alpha-subunit.
    Tavernier J; Van der Heyden J; Verhee A; Brusselle G; Van Ostade X; Vandekerckhove J; North J; Rankin SM; Kay AB; Robinson DS
    Blood; 2000 Mar; 95(5):1600-7. PubMed ID: 10688814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biologics for the Treatment of Allergic Conditions: Eosinophil Disorders.
    Olivieri B; Tinazzi E; Caminati M; Lunardi C
    Immunol Allergy Clin North Am; 2020 Nov; 40(4):649-665. PubMed ID: 33012326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathogenesis of murine experimental allergic rhinitis: a study of local and systemic consequences of IL-5 deficiency.
    Saito H; Matsumoto K; Denburg AE; Crawford L; Ellis R; Inman MD; Sehmi R; Takatsu K; Matthaei KI; Denburg JA
    J Immunol; 2002 Mar; 168(6):3017-23. PubMed ID: 11884474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The GM-CSF/IL-3/IL-5 cytokine receptor family: from ligand recognition to initiation of signaling.
    Broughton SE; Dhagat U; Hercus TR; Nero TL; Grimbaldeston MA; Bonder CS; Lopez AF; Parker MW
    Immunol Rev; 2012 Nov; 250(1):277-302. PubMed ID: 23046136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon-gamma enhances human eosinophil effector functions induced by granulocyte-macrophage colony-stimulating factor or interleukin-5.
    Yamaguchi T; Kimura H; Kurabayashi M; Kozawa K; Kato M
    Immunol Lett; 2008 Jun; 118(1):88-95. PubMed ID: 18440651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elimination of eosinophils using anti-IL-5 receptor alpha antibodies effectively suppresses IL-33-mediated pulmonary arterial hypertrophy.
    Ikutani M; Ogawa S; Yanagibashi T; Nagai T; Okada K; Furuichi Y; Takatsu K
    Immunobiology; 2018; 223(6-7):486-492. PubMed ID: 29269115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a novel IL-5 signaling pathway in chronic pancreatitis and crosstalk with pancreatic tumor cells.
    Gitto SB; Beardsley JM; Nakkina SP; Oyer JL; Cline KA; Litherland SA; Copik AJ; Khaled AS; Fanaian N; Arnoletti JP; Altomare DA
    Cell Commun Signal; 2020 Jun; 18(1):95. PubMed ID: 32552827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-5 and its receptor: which role do they play in the immune response?
    Koike M; Takatsu K
    Int Arch Allergy Immunol; 1994 May; 104(1):1-9. PubMed ID: 7950399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of IL-5 receptor on eosinophil progenitors in allergic inflammation: role of retinoic acid.
    Denburg JA; Sehmi R; Upham J
    Int Arch Allergy Immunol; 2001; 124(1-3):246-8. PubMed ID: 11306982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.